van der Bol, Jessica M <br/><br/>
A CYP3A4 phenotype-based dosing algorithm for individualized treatment of irinotecan.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Jan 2010 
 - 736-42 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-09-1526  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Algorithms<br/>Antineoplastic Agents, Phytogenic--administration & dosage<br/>Camptothecin--administration & dosage<br/>Carcinoma--drug therapy<br/>Colorectal Neoplasms--drug therapy<br/>Cytochrome P-450 CYP3A--genetics<br/>Drug Dosage Calculations<br/>Female<br/>Humans<br/>Individuality<br/>Irinotecan<br/>Male<br/>Midazolam--administration & dosage<br/>Middle Aged<br/>Models, Biological<br/>Neoplasm Metastasis<br/>Phenotype<br/>Precision Medicine--methods<br/>Prodrugs--administration & dosage